 United States SAFEVAX
|
| Created Date: |
8/13/2008 8:58:06 AM |
| Country: |
United Republic of Tanzania |
| Focus: |
Electronic and Mobile Government,
Institution and HR Management,
Internet Governance
|
| Status: |
Not Specified whether in use |
| License: |
Proprietary |
| Product Type: |
Software - Mobile |
| Target Users: |
Government Agency |
| Developer Name: |
Voxiva |
| Product Url: |
http://www.voxiva.com/safevax.asp |
| System Requirements: |
NA |
| Description: |
After September 11, concern about weaponized smallpox led Voxia’s client to vaccinate its personnel against the disease. As data on the effects of the smallpox vaccine were more than 30 years old, and because of changing demography and health status of the U.S. population, Voxiva’s client wanted to closely monitor the recipients of the vaccine. The objectives were to protect personnel against infection, and also protect against any adverse effects of the vaccine.
In collaboration with Abt Associates, Voxiva developed SAFEVAX, an adverse event reporting solution that enables rapid identification of vaccine reactions, analysis of reaction patterns and trends. It also provides for an automatic alert and notification. Criteria can be specified (e.g. fever over 103 degrees) that would result in an automatic telephone or e-mail notification being sent to the appropriate person. Each vaccinee, using a secure ID and Password, reports “ Take” and reaction data on a daily basis via phone or the Internet. If vaccinees don’t report on schedule, they receive a reminder call from a call center operator who can help them submit their data. To ensure security, Voxiva hosts SAFEVAX at a carrier grade, HIPAA-compliant facility. Data collected is available only to designated and authorized personnel. The data is collected and stored in a centralized database where it can be viewed or forwarded in common formats for further manipulation and analysis.
|
|
 Tag This |
United States SAFEVAX After September 11 concern about weaponized smallpox led Voxia’s client nbsp to vaccinate its personnel against the disease As data on the effects of the smallpox vaccine were more than 30 years old and because of changing demography and health status of the U.S population Voxiva’s client wanted to closely monitor the recipients of the vaccine The objectives were to protect personnel against infection and also protect against any adverse effects of the vaccine nbsp nbsp nbsp In collaboration with Abt Associates Voxiva developed SAFEVAX an adverse event reporting solution that enables rapid identification of vaccine reactions analysis of reaction patterns and trends It also provides for an automatic alert and notification Criteria can be specified e.g fever over 103 degrees that would result in an automatic telephone or e-mail notification being sent to the appropriate person Each vaccinee using a secure ID and Password reports “ Take” and reaction data on a daily basis via phone or the Internet If vaccinees don’t repor
 Tell A Friend |
 del.icio.us digg this Slashdot |
| Rate: |
0 ratings
|
Views: |
1085 |
| Comments: |
0 |
Bookmarked: |
0 |
Tagged: |
0 |
|